Promising Strategy Identifies Triple-Negative Breast Cancers That Might Respond to Tamoxifen Promising Strategy Identifies Triple-Negative Breast Cancers That Might Respond to Tamoxifen

Triple-negative breast cancer (TNBC) tumors with estrogen receptor-beta and a mutated p53 tumor suppressor might be responsive to tamoxifen, a series of preclinical studies suggests.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news